Clinical Trials Directory

Trials / Completed

CompletedNCT03587324

Perioperative Aspirin Response in Patients Undergoing Vascular Surgery

Perioperative Risk Factors for the Development of Aspirin Low Response in Patients Undergoing Vascular Surgery.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
176 (actual)
Sponsor
St. Josef Hospital Bochum · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Reduced antiplatelet activity (low response (LR)/high on-treatment platelet reactivity (HPR)) of aspirin (ALR) or clopidogrel (CLR) is associated with an increased risk of thromboembolic events. The prevalence figures for low-responders reported in the literature vary widely and there have been few investigations in vascular surgery patients to date. The aim of this prospective monocentric study was to increase the evidence base on vascular surgery patients and to detect any changes in the response following vascular surgery procedures.

Detailed description

The activity of aspirin (acetylsalicylic acid, ASA) and clopidogrel is measured by whole blood impedance aggregometry using a multiple electrode aggregometer (Multiplate). The agonists used are arachidonic acid for aspirin and adenosine diphosphate (ADP) for clopidogrel. Vascular patients requiring treatment for peripheral artery disease (PAD) and/or carotid stenosis are included in the study. To identify possible risk factors demographic data, concomitant medication, laboratory parameters, co-morbidities, severity of the condition and the type of procedure performed are documented. In addition, a follow-up aggregometry is performed after completion of the vascular procedure.

Conditions

Interventions

TypeNameDescription
DRUGWhole blood aggregometry before and after vascular treatment (ASA/ Clopidogrel).To identify possible risk factors demographic data, concomitant medication, laboratory parameters, co-morbidities, severity of the condition and the type of procedure performed are documented. Other Name: ASA (aspirin), Clopidogrel (Plavix)

Timeline

Start date
2013-02-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2018-07-16
Last updated
2018-07-18

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03587324. Inclusion in this directory is not an endorsement.